Combivir and Klonopin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivir (lamivudine; zidovudine) and Klonopin (clonazepam). Common drug interactions include gout among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Combivir and Klonopin. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Combivir?

Combivir has active ingredients of lamivudine; zidovudine. It is often used in hiv infection. eHealthMe is studying from 15,450 Combivir users. Check the latest studies of Combivir.

What is Klonopin?

Klonopin has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 65,112 Klonopin users. Check the latest studies of Klonopin.



On Jul, 13, 2026

51 people who take Combivir and Klonopin together, and have interactions are studied.

Combivir and Klonopin drug interactions.

What are the common drug interactions of Combivir and Klonopin, by gender? *:

female:

  1. Gout (uric acid crystals building up in the body)
  2. Hand fracture
  3. Headache (pain in head)
  4. Pancreatitis acute (sudden inflammation of pancreas)
  5. Renal failure (kidney dysfunction)
  6. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Angina pectoris (chest pain due to ischemia of the heart muscle)
  9. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  10. Blood cholesterol increased

male:

  1. Emotional distress
  2. Pain
  3. Osteoporosis (bones weak and more likely to break)
  4. Proteinuria (presence of protein in the urine)
  5. Quality of life decreased
  6. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Impaired work ability

What are the common drug interactions of Combivir and Klonopin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Drug screen positive
  3. Transaminases increased
  4. Abdominal distension
  5. Abnormal dreams
  6. Blood creatinine increased
  7. Blood urea increased
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Diarrhoea

40-49:

  1. Hypersensitivity
  2. Ileus (a painful obstruction of the ileum or other part of the intestine)
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Loose tooth
  5. Multiple fractures
  6. Oropharyngeal plaque (hard deposit on oropharynx)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Osteoporosis (bones weak and more likely to break)
  10. Pancreatitis (inflammation of pancreas)

50-59:

  1. Osteoporosis (bones weak and more likely to break)
  2. Proteinuria (presence of protein in the urine)
  3. Quality of life decreased
  4. Back pain
  5. Depression
  6. Osteonecrosis (death of bone)
  7. Asthenia (weakness)
  8. Gait disturbance
  9. Gout (uric acid crystals building up in the body)
  10. Oedema peripheral (superficial swelling)

60+:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Sinus congestion (blockage of sinus)
  4. Vomiting

What are the existing conditions these people have? *

  1. Hiv Infection: 30 people, 58.82%
  2. High Blood Pressure: 12 people, 23.53%
  3. Depression: 10 people, 19.61%
  4. Pain: 8 people, 15.69%
  5. Asthma: 5 people, 9.80%
  6. Gastric Ulcer (stomach ulcer): 5 people, 9.80%
  7. Bacterial Infection: 4 people, 7.84%
  8. Chest Pain: 4 people, 7.84%
  9. Constipation: 4 people, 7.84%
  10. Diabetes: 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Combivir and Klonopin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Combivir and Klonopin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Combivir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klonopin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klonopin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine and clonazepam (the active ingredients of Combivir and Klonopin, respectively), and Combivir and Klonopin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: